HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of canine dirofilariasis: pulmonary thromboembolism caused by thiacetarsamide--microscopic changes.

Abstract
Light and scanning electron microscopies were used to study the pulmonary embolism occurring in Dirofilaria immitis-infected dogs after treatment with thiacetarsamide. Lesions in control dogs (nontreated) which had been infected for 4 weeks with 9 Dirofilaria immitis adults were compared with lesions occurring in infected dogs at 2 weeks and at 4 weeks after they were treated with the adulticide. Extensive thromboembolism occurred in the caudal lobar pulmonary arteries of dogs at posttreatment weeks 2 and 4. Complicated villous proliferations were present at posttreatment week 2. The characteristic myointimal proliferation of dirofilariasis showed resolution in the large pulmonary arteries of the dogs at week 4. However, the caudal lobar pulmonary arterial and lung lesions were more severe in the later group. The pathophysiology of adulticide-induced thromboembolism and associated lung parenchymal changes were discussed.
AuthorsJ C Keith Jr, C A Rawlings, R G Schaub
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 44 Issue 7 Pg. 1272-7 (Jul 1983) ISSN: 0002-9645 [Print] United States
PMID6881665 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arsenicals
  • Arsenamide
Topics
  • Animals
  • Arsenamide (adverse effects, therapeutic use)
  • Arsenicals (adverse effects)
  • Dirofilariasis (drug therapy, pathology, veterinary)
  • Dog Diseases (chemically induced, drug therapy, pathology)
  • Dogs
  • Lung (pathology)
  • Microscopy, Electron, Scanning
  • Pulmonary Artery (ultrastructure)
  • Pulmonary Embolism (chemically induced, pathology, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: